Compare, Analyse IPCA Labs with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs MYLAN (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   MYLAN
EQUITY SHARE DATA
    IPCA LABS
Mar-18
MYLAN
Dec-18
IPCA LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6953,398-   
Low Rs4001,870-   
Sales per share (Unadj.) Rs260.21,563.6-  
Earnings per share (Unadj.) Rs19.042.5-  
Cash flow per share (Unadj.) Rs33.1335.2-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs213.01,691.6-  
Shares outstanding (eoy) m126.20514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.11.7 124.9%   
Avg P/E ratio x28.962.0 46.5%  
P/CF ratio (eoy) x16.67.9 210.9%  
Price / Book Value ratio x2.61.6 165.1%  
Dividend payout %5.30-   
Avg Mkt Cap Rs m69,1201,355,343 5.1%   
No. of employees `00013.335.0 37.9%   
Total wages/salary Rs m7,3590-   
Avg. sales/employee Rs Th2,477.422,985.5 10.8%   
Avg. wages/employee Rs Th555.20-   
Avg. net profit/employee Rs Th180.6624.2 28.9%   
INCOME DATA
Net Sales Rs m32,836804,494 4.1%  
Other income Rs m4180-   
Total revenues Rs m33,254804,494 4.1%   
Gross profit Rs m4,505208,173 2.2%  
Depreciation Rs m1,777150,633 1.2%   
Interest Rs m24038,693 0.6%   
Profit before tax Rs m2,90518,847 15.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m511-2,998 -17.0%   
Profit after tax Rs m2,39421,845 11.0%  
Gross profit margin %13.725.9 53.0%  
Effective tax rate %17.6-15.9 -110.6%   
Net profit margin %7.32.7 268.5%  
BALANCE SHEET DATA
Current assets Rs m19,455449,229 4.3%   
Current liabilities Rs m10,076327,537 3.1%   
Net working cap to sales %28.615.1 188.8%  
Current ratio x1.91.4 140.8%  
Inventory Days Days9884 117.1%  
Debtors Days Days6793 71.7%  
Net fixed assets Rs m20,260156,059 13.0%   
Share capital Rs m252428 58.9%   
"Free" reserves Rs m26,6330-   
Net worth Rs m26,886870,315 3.1%   
Long term debt Rs m2,340939,350 0.2%   
Total assets Rs m41,1732,334,524 1.8%  
Interest coverage x13.11.5 880.6%   
Debt to equity ratio x0.11.1 8.1%  
Sales to assets ratio x0.80.3 231.4%   
Return on assets %6.42.6 246.7%  
Return on equity %8.92.5 354.8%  
Return on capital %10.83.2 338.5%  
Exports to sales %47.60-   
Imports to sales %14.90-   
Net fx Rs m10,7590-   
CASH FLOW
From Operations Rs m3,411167,174 2.0%  
From Investments Rs m-1,354-86,410 1.6%  
From Financial Activity Rs m-1,304-77,879 1.7%  
Net Cashflow Rs m7531,385 54.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare IPCA LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: TTK HEALTHCARE  STRIDES PHARMA SCIENCE  ABBOTT INDIA  STERLING BIOTECH  AJANTA PHARMA  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Oct 17, 2019 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS